CoChat

New-Onset Diabetes Mellitus Associated with Use of Protease Inhibitor

Eastone, John A., Decker, Catherine F. · 1997 · Annals of Internal Medicine
Cited by 122

The DOI matches its Crossref record.

Abstract

Letters15 November 1997New-Onset Diabetes Mellitus Associated with Use of Protease InhibitorJohn A. Eastone, MD and Catherine F. Decker, MDJohn A. Eastone, MDNational Naval Medical Center; Bethesda, MD 20889 and Catherine F. Decker, MDNational Naval Medical Center; Bethesda, MD 20889Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-127-10-199711150-00017 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:The use of protease inhibitors has revolutionized the treatment of HIV infection through the ability of these drugs to decrease viral load [1]. Although these agents are fairly well tolerated, previously unrecognized adverse reactions will become more evident as the availability of the drugs improves and use becomes more widespread. New-onset diabetes mellitus has been described with several agents commonly used to manage HIV disease [2-4]. We noted a strong temporal relation between the onset of hyperglycemia and the initiation or change in protease inhibitor therapy in five HIV-infected patients.The Table 1 shows the characteristics of ...References1. Bartlett J. Protease inhibitors for HIV infection. Am J Med. 1996; 124:1086-8. Google Scholar2. Nasti G, Zanette G, Inchiostro S, Donadon V, Tirelli U. Diabetes mellitus following intravenous pentamidine administration in a patient with HIV infection. Arch Intern Med. 1995; 155:645-6. Google Scholar3. Henry K, Rathgaber S, Sullivan C, McCabe K. Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia. Ann Intern Med. 1992; 116:53-4. Google Scholar4. Albrecht H, Stellbrink HJ, Arastéh K. Didanosine-induced disorders of glucose intolerance. Ann Intern Med. 1993;119:1050. Google Scholar5. Mellors JW, McMahon DK, Chodakewitz JA, Schleif WA, Emini EA, Condra IH. Correlation between genotypic evidence of HIV-1 resistance to the protease inhibitor MK-639 and loss of antiretroviral effect in treated patients [Abstract]. In: Program and Abstracts of the Fourth International Workshop on HIV Drug Resistance, 6-9 July 1995, Sardinia, Italy. Google Scholar Author, Article, and Disclosure InformationAffiliations: National Naval Medical Center; Bethesda, MD 20889 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByHIVAN, AdultDiabetes and HIVEndocrine and Metabolic Emergencies in HIV/AIDSImpact of Protease Inhibitor-Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant RecipientsHIVAN, AdultInfections virales et diabète en AfriqueDiabetes and Dyslipidemia in Treated Human Immunodeficiency Virus Infection and Approaches for Cardiometabolic CareA Randomized Controlled Trial to Assess Safety, Tolerability, and Antepartum Viral Load with Increased Lopinavir/Ritonavir Dosage in PregnancyHIV and diabetesNutrition and the HIV-associated lipodystrophy syndromeThe Burden of Diabetes and Hyperlipidemia in Treated HIV Infection and Approaches for Cardiometabolic CareThe prevalence and pathogenesis of diabetes mellitus in treated HIV-infectionIssues of Prematurity and HIV InfectionPediatric antiretroviral therapyGastrointestinal and Hepatobiliary Manifestations of Human Immunodeficiency Virus InfectionEffect of HCV Infection on Glucose Metabolism in Pregnant Women with HIV Receiving HAARTHow sweet it is? Susceptibility to diabetes mellitus in HIV-1 treatmentPrevalence and Pathogenesis of Diabetes Mellitus in HIV-1 Infection Treated With Combined Antiretroviral TherapyLipid Profile of Infected Patients Treated with Highly Active Antiretroviral Therapy in CameroonDrug-induced diabetes mellitusUnusual Thromboses Associated with Protein S Deficiency in Patients with Acquired Immunodeficiency Syndrome: Case Reports and Review of the LiteratureGuidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIVOral Glucose Tolerance and Insulin Sensitivity Are Unaffected by HIV Infection or Antiretroviral Therapy in Overweight WomenImproved Obstetric Outcomes and Few Maternal Toxicities Are Associated With Antiretroviral Therapy, Including Highly Active Antiretroviral Therapy During PregnancyProtease Inhibitor-Induced Diabetic ComplicationsTolerability and Safety of HIV Protease Inhibitors in AdultsSafety and Pharmacokinetics of Antiretroviral Therapy During PregnancyRestoration of Human Immunodeficiency Virus-1-Specific Responses in Patients Changing from Protease to Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral TherapyOlder HIV Patients Face Metabolic ComplicationsFactors associated with the development of diabetes mellitus in HIV-infected patients on antiretroviral therapyEffects of HIV protease inhibitor therapy on lipid metabolismHIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin DEarly Versus Delayed Antiretroviral Therapy in Patients with HIV InfectionMetabolic Complications Associate

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-127-10-199711150-00017

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Metadata

Authors
Eastone, J. A., & Decker, C. F.
Venue
Annals of Internal Medicine
Published
1997-11-15
Volume
127
Issue
10
Pages
948
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2023294622
Cited by
122
References
0
FWCI
22.73
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: New-Onset Diabetes Mellitus Associated with Use of Protease Inhibitor. https://app.cochat.ai/papers/10.7326/0003-4819-127-10-199711150-00017
The paper
Eastone, J. A., & Decker, C. F. (1997). New-Onset Diabetes Mellitus Associated with Use of Protease Inhibitor. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-127-10-199711150-00017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.